| Literature DB >> 35206350 |
Shuko Takahashi1,2,3, Yuki Yonekura4, Nobuyuki Takanashi5, Kozo Tanno5.
Abstract
This study aimed to review evidence on future long-term care associated with pre-existing factors among community-dwelling Japanese older adults. We systematically searched cohort and nested case-control studies published between 2000 and 2019 that assessed long-term care certification using the PubMed, CINAHL, and EMBASE databases. The relationship between long-term care insurance information and risk factors was investigated. The protocol was registered with the Open Science Framework. We extracted 91 studies for synthesis, including 84 prospective cohort studies, 1 retrospective cohort study, and 6 nested case-control studies. Certification for long-term care was classified into two endpoints: onset of functional disability and dementia. There were 72 studies that used long-term care certification as a proxy for functional disability, and 22 used long-term care information to indicate the onset of dementia. Common risk factors related to functional disability were physical function, frailty, and oral condition. Motor function and nutritional status were common risk factors for dementia. We found consistent associations between premorbid risk factors and functional disability and dementia. The accumulation of evidence on the incidence of long-term care and associated factors can aid the development of preventive measures. Future studies should aim to integrate this evidence.Entities:
Keywords: Japan; dementia; functional disability; long-term care; longitudinal studies
Mesh:
Year: 2022 PMID: 35206350 PMCID: PMC8872097 DOI: 10.3390/ijerph19042162
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Figure 1Flowchart of the literature review.
Classification of endpoints in the reviewed articles.
|
| % | |
|---|---|---|
| Functional disability | 72 | |
| All Support/Care Need Levels | 64 | 88.9% |
| Above specific level | 10 | 13.9% |
| Care Need Level 2 | 7 | 9.7% |
| Care Need Level 3 | 3 | 4.2% |
| Composite endpoint with death | 12 | 16.7% |
| Analysis on cause of disability | 2 | 2.8% |
| Stroke | 2 | 2.8% |
| Joint | 2 | 2.8% |
| Other | 1 | 1.4% |
| Dementia | 22 | |
| Dementia scale rank II or above | 20 | 90.9% |
| Primary physician’s comment | 2 | 9.1% |
| Composite endpoint with death | 2 | 9.1% |
| Analysis of cause of disability | 4 | 18.2% |
| Stroke | 4 | 18.2% |
| Joint | 0 | 0.0% |
| Other | 0 | 0.0% |
Studies that employed both functional disability and dementia as outcomes were counted in each category.
Number of articles by combination of endpoint and risk factor.
| Risk Factor | Endpoint | |||
|---|---|---|---|---|
| Category | Functional Disability | Dementia | Total | |
| Physical condition | 15 | 3 | 17 | |
| Motor function | 9 | 0 | 9 | |
| Physical frailty and sarcopenia | 4 | 0 | 4 | |
| Chewing ability | 3 | 0 | 3 | |
| Leisure-time physical activity | 1 | 1 | 1 | |
| Walking | 0 | 2 | 2 | |
| Falls | 2 | 0 | 2 | |
| Other physical function | 1 | 0 | 1 | |
| Lifestyle | 6 | 7 | 13 | |
| Smoking | 0 | 2 | 2 | |
| Nutrition | 3 | 5 | 8 | |
| Sleep | 1 | 1 | 2 | |
| Combination of healthy lifestyle behaviors | 2 | 0 | 2 | |
| Other lifestyle factors | 1 | 0 | 1 | |
| Dental status | 7 | 1 | 8 | |
| Medical history | 17 | 2 | 18 | |
| Hospitalization | 2 | 0 | 2 | |
| Vascular diseases | 1 | 1 | 2 | |
| Chronic kidney disease | 4 | 1 | 4 | |
| Cognitive dysfunction | 5 | 0 | 5 | |
| Psychological difficulties | 4 | 0 | 4 | |
| Sensory organ abnormalities | 1 | 0 | 1 | |
| Pain | 1 | 0 | 1 | |
| Blood tests and clinical examinations | 12 | 4 | 15 | |
| Blood tests | 7 | 3 | 10 | |
| Clinical examinations (except blood tests) | 2 | 0 | 2 | |
| Body mass index | 3 | 1 | 3 | |
| Social factors | 13 | 3 | 16 | |
| Social participation, social support, social capital, and social frailty | 4 | 1 | 5 | |
| Social network | 4 | 0 | 4 | |
| Living arrangements | 2 | 0 | 2 | |
| Food availability | 1 | 1 | 2 | |
| Other social factors | 4 | 1 | 5 | |
| Kihon Checklist as a predictive tool for disability | 6 | 0 | 6 | |
| Others | 1 | 1 | 2 | |
Studies that corresponded to multiple categories were counted in each category. Thus, the sum of categories does not match the total number of reviewed cases (N = 91). Even if one study corresponded to multiple subcategories within the same category, the category count was counted as one case. Therefore, the sum of the subcategories does not match the frequency of the category.
|
|
|
| |
|
| |||
| Title | 1 | Identify the report as a scoping review. | 1 |
|
| |||
| Structured summary | 2 | Provide a structured summary that includes (as applicable): background, objectives, eligibility criteria, sources of evidence, charting methods, results, and conclusions that relate to the review questions and objectives. | 1 |
|
| |||
| Rationale | 3 | Describe the rationale for the review in the context of what is already known. Explain why the review questions/objectives lend themselves to a scoping review approach. | 1–2 |
| Objectives | 4 | Provide an explicit statement of the questions and objectives being addressed with reference to their key elements (e.g., population or participants, concepts, and context) or other relevant key elements used to conceptualize the review questions and/or objectives. | 2 |
|
| |||
| Protocol and registration | 5 | Indicate whether a review protocol exists; state if and where it can be accessed (e.g., a Web address); and if available, provide registration information, including the registration number. | 2 |
| Eligibility criteria | 6 | Specify characteristics of the sources of evidence used as eligibility criteria (e.g., years considered, language, and publication status), and provide a rationale. | 2 |
| Information sources * | 7 | Describe all information sources in the search (e.g., databases with dates of coverage and contact with authors to identify additional sources), as well as the date the most recent search was executed. | 2–3 |
| Search | 8 | Present the full electronic search strategy for at least 1 database, including any limits used, such that it could be repeated. |
|
| Selection of sources of evidence † | 9 | State the process for selecting sources of evidence (i.e., screening and eligibility) included in the scoping review. | 3 |
| Data charting process ‡ | 10 | Describe the methods of charting data from the included sources of evidence (e.g., calibrated forms or forms that have been tested by the team before their use, and whether data charting was done independently or in duplicate) and any processes for obtaining and confirming data from investigators. |
|
| Data items | 11 | List and define all variables for which data were sought and any assumptions and simplifications made. | 2–3 |
| Critical appraisal of individual sources of evidence § | 12 | If done, provide a rationale for conducting a critical appraisal of included sources of evidence; describe the methods used and how this information was used in any data synthesis (if appropriate). | NA |
| Synthesis of results | 13 | Describe the methods of handling and summarizing the data that were charted. | 2–3 |
|
| |||
| Selection of sources of evidence | 14 | Give numbers of sources of evidence screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally using a flow diagram. | 3 |
| Characteristics of sources of evidence | 15 | For each source of evidence, present characteristics for which data were charted and provide the citations. | 3–10 |
| Critical appraisal within sources of evidence | 16 | If done, present data on critical appraisal of included sources of evidence (see item 12). | NA |
| Results of individual sources of evidence | 17 | For each included source of evidence, present the relevant data that were charted that relate to the review questions and objectives. | 3–10 |
| Synthesis of results | 18 | Summarize and/or present the charting results as they relate to the review questions and objectives. | 3–10 |
|
| |||
| Summary of evidence | 19 | Summarize the main results (including an overview of concepts, themes, and types of evidence available), link to the review questions and objectives, and consider the relevance to key groups. | 10–11 |
| Limitations | 20 | Discuss the limitations of the scoping review process. | 11 |
| Conclusions | 21 | Provide a general interpretation of the results with respect to the review questions and objectives, as well as potential implications and/or next steps. | 11 |
|
| |||
| Funding | 22 | Describe sources of funding for the included sources of evidence, as well as sources of funding for the scoping review. Describe the role of the funders of the scoping review. | 11 |
JBI = Joanna Briggs Institute; PRISMA-ScR = Preferred Reporting Items for Systematic reviews and Meta-Analyses extension for Scoping Reviews. * Where sources of evidence (see second footnote) are compiled from, such as bibliographic databases, social media platforms, and Web sites. † A more inclusive/heterogeneous term used to account for the different types of evidence or data sources (e.g., quantitative and/or qualitative research, expert opinion, and policy documents) that may be eligible in a scoping review as opposed to only studies. This is not to be confused with information sources (see first footnote). ‡ The frameworks by Arksey and O’Malley (6) and Levac and colleagues (7) and the JBI guidance (4, 5) refer to the process of data extraction in a scoping review as data charting. § The process of systematically examining research evidence to assess its validity, results, and relevance before using it to inform a decision. This term is used for items 12 and 19 instead of “risk of bias” (which is more applicable to systematic reviews of interventions) to include and acknowledge the various sources of evidence that may be used in a scoping review (e.g., quantitative and/or qualitative research, expert opinion, and policy document). From: Tricco AC, Lillie E, Zarin W, O’Brien KK, Colquhoun H, Levac D, et al. PRISMA Extension for Scoping Reviews (PRISMAScR): Checklist and Explanation. Ann Intern Med. 2018;169:467–473. doi: 10.7326/M18-0850.